Oh sorry
just one more titbit you probably already know
the next cohort group being iv’d at 3x or 150 mg
is likely on past extrapolated assessments been the efficacious level of administration to defeat sepsis rapidly
all the levels above this are as required by formulae to seek out the toxic threshold of safety
the point of the exercise
but 10 x efficacious sounds like a winner to me
Ann: Positive Safety Data from Phase 1 Clinical Trial, page-33
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
-0.025(5.62%) |
Mkt cap ! $121.4M | |||
| Open | High | Low | Value | Volume |
| 44.0¢ | 44.0¢ | 41.5¢ | $45.92K | 107.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 120 | 42.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.0¢ | 1000 | 1 |
View Market Depth
| Last trade - 15.59pm 28/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |